Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Roden

Showing results (181-190 of 237) with videos related to

Pageof 24
Sort By:
The American Journal of Cardiology|May 1, 1986
Concentration-dependent pharmacologic properties of sotalolT Wang, R H Bergstrand, K A Thompson, et al.
Circulation|April 1, 1987
Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequencesL A Siddoway, K A Thompson, C B McAllister, et al.
The American Journal of Cardiology|February 1, 1985
Bretylium: relations between plasma concentrations and pharmacologic actions in high-frequency ventricular arrhythmiasH J Duff, D M Roden, A Yacobi, et al.
Clinical Pharmacology and Therapeutics|May 27, 2008
Development of a large-scale de-identified DNA biobank to enable personalized medicineD M Roden, J M Pulley, M A Basford, et al.
The New England Journal of Medicine|April 17, 1980
Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristicsD M Roden, S B Reele, S B Higgins, et al.
Southern Medical Journal|September 1, 1981
Recurrent ventricular tachycardia in the absence of overt heart disease: clinical characteristics and response to drug therapyD M Roden, H J Duff, S B Reele, et al.
Clinical Pharmacology and Therapeutics|May 1, 1989
Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testingK T Murray, J T Barbey, H A Kopelman, et al.
The American Journal of Cardiology|September 1, 1980
Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamideD M Roden, S B Reele, S B Higgins, et al.
Clinical Pharmacology and Therapeutics|May 1, 1988
The development and testing of intravenous dosing regimens: application to flecainide for the suppression of ventricular arrhythmiasT Wang, L A Siddoway, K A Thompson, et al.
American Heart Journal|March 1, 1984
Molecular basis for the antigenicity of lidocaine analogs: tocainide and mexiletineH J Duff, D M Roden, S Marney, et al.
Pageof 24

Showing results (181-190 of 237) with videos related to

Sort By:
Pageof 24
The American Journal of Cardiology|May 1, 1986
Concentration-dependent pharmacologic properties of sotalolT Wang, R H Bergstrand, K A Thompson, et al.
Circulation|April 1, 1987
Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequencesL A Siddoway, K A Thompson, C B McAllister, et al.
The American Journal of Cardiology|February 1, 1985
Bretylium: relations between plasma concentrations and pharmacologic actions in high-frequency ventricular arrhythmiasH J Duff, D M Roden, A Yacobi, et al.
Clinical Pharmacology and Therapeutics|May 27, 2008
Development of a large-scale de-identified DNA biobank to enable personalized medicineD M Roden, J M Pulley, M A Basford, et al.
The New England Journal of Medicine|April 17, 1980
Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristicsD M Roden, S B Reele, S B Higgins, et al.
Southern Medical Journal|September 1, 1981
Recurrent ventricular tachycardia in the absence of overt heart disease: clinical characteristics and response to drug therapyD M Roden, H J Duff, S B Reele, et al.
Clinical Pharmacology and Therapeutics|May 1, 1989
Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testingK T Murray, J T Barbey, H A Kopelman, et al.
The American Journal of Cardiology|September 1, 1980
Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamideD M Roden, S B Reele, S B Higgins, et al.
Clinical Pharmacology and Therapeutics|May 1, 1988
The development and testing of intravenous dosing regimens: application to flecainide for the suppression of ventricular arrhythmiasT Wang, L A Siddoway, K A Thompson, et al.
American Heart Journal|March 1, 1984
Molecular basis for the antigenicity of lidocaine analogs: tocainide and mexiletineH J Duff, D M Roden, S Marney, et al.
Pageof 24